Citigroup Inc Athersys, Inc Transaction History

Citigroup Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	SELL	$0.18 - $0.86 $2,340 - $11,181	-13,002 Reduced 85.49%	2,207 $1,000
Q1 2022 May 12, 2022	SELL	$0.6 - $1.06 $22,611 - $39,946	-37,685 Reduced 71.25%	15,209 $9,000
Q4 2021 Feb 10, 2022	BUY	$0.85 - $1.4 $21,158 - $34,848	24,892 Added 88.89%	52,894 $48,000
Q3 2021 Nov 10, 2021	BUY	$1.33 - $1.77 $37,242 - $49,563	28,002 New	28,002 $37,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.